Cooley has one of the leading litigation practices in the country with many seasoned trial lawyers. Our experience litigating in a wide variety of venues includes the United States Supreme Court and other federal and state courts nationwide, a broad spectrum of administrative tribunals and international arbitral forums. Cooley attorneys have considerable experience as coordinating counsel in multi-district litigation and are also experienced in a variety of alternative dispute resolution forums, including mediations and settlement conferences. Many of our litigators serve as court appointed or privately selected mediators and arbitrators.
- 325 Litigation attorneys in nine major business and technology centers nationwide
- Experience in more than 80 state and federal courts, arbitral forums and administrative bodies
- Argued recently in U.S. and California Supreme Courts – only firm to be awarded Ninth Circuit recognition
- Department partners include former US Attorneys, many former Assistant US Attorneys, Department of Justice lawyers
Our clients include leading companies of all sizes from new, emerging companies to Fortune 50 and 100 public companies across many industries, such as capital markets, entertainment and media, transportation, insurance, military contracting, and accounting, with a particular focus on technology companies and financial institutions in all sectors. We have a deep understanding of what these businesses do and what they expect and need from their litigators.
While our team is comprised of skilled litigators who repeatedly win jury verdicts in favor of our clients, we appreciate that litigation, and ultimately trial, is not always the best answer. To this end, we offer a broad range of pre-litigation counseling, so that our clients can avoid litigation when possible. We work with each of our clients to achieve the best outcome under the circumstances, in the most prompt and cost-efficient manner.
Case in Point
Onyx Pharmaceuticals, Inc. v. Bayer Corp. et al.
Cooley delivered a significant win for longtime client Onyx Pharmaceuticals in a dispute with its partner, the international pharmaceutical company, Bayer. The case revolved around the collaboration between the two companies on a new class of anti-cancer compounds known as DAST. When Onyx obtained its principal litigation objective – a significant stake in DAST – in the middle of a federal trial, the Cooley team negotiated a settlement that included a $160 million lump sum payment to Onyx, ongoing royalties and several new sources of revenue for the company. Read more